Monoclonal Antibody Production Request Form
Monoclonal Antibody (MAb) Production
Unit
Contact Personnel: Stuart Balaban -
BIGGS/C612 473-7334
Core Director: Dr. David Lawrence --
BIGGS/C539 402-5684
- Requestor
-
NAME:
PRINCIPAL INVESTIGATOR:
LAB ROOM #____________ Phone #____________________________
- Request monoclonal antibodies (MAbs) to:
-
- Single or multiple specificity to epitope(s) of
antigen needed: ____________
- Specific isotype(s) needed:
_____________________________________
- Describe antigen; its purity, quantity,
pathogenicity, etc:
- Single or multiple specificity to epitope(s) of
antigen needed: ____________
- Justify the need for MAbs including their potential role in public health or their necessary utility in your research program:
-
- Provide verification that a search has been performed to document that monoclonal antibodies do not exist to this antigen.
-
- Describe the objectives to be achieved with these MAbs and how these MAbs will be used, e.g., disease diagnosis, identification of microorganisms, inhibition of receptors, etc.:
-
- Need for a screening test:
-
Assay for screening is established in my lab.________
Screening is by _____________________________
Assay sensitivity is ___________________________
Request for development of screening test by MAb Unit. [Form]: BIAcore/Biosensor Analysis Request Form
Requestor will provide antigen, quantity:
- Amount of antigen to be provided for monoclonal antibody productin and characteristics of the antigen (toxicity, infectivity, et.):
-
________________________________________________________
Please Note: Questions or comments regarding animals for mab production should be directed to IACUC.
- FUNDING INFORMATION: REQUIRED BEFORE USAGE)
-
HRI ACCOUNT# ___________________________ STATE ACCOUNT# __________________
Please contact core personnel about the charge fee for usage.
PI will be billed quarterly.___ I agree that the Immunology Core is an essential active participant in the development of all MAbs. I further agree to provide all information on characterization of the antibodies and their use in publications and/or patent applications.
APPROVED BY: (ALL SIGNATURES ARE REQUIRED BEFORE USAGE)
PI: _________________________________________ DATE: _________
LAB CHIEF: _________________________________DATE: _________
CORE DIRECTOR: __________________________ DATE: _________
Print & Send completed form to:
Core Contact Personnel Stuart Balaban - BIGGS, C612. Phone 473-7334, Fax 486-1505
Or Core Director, Dr. David Lawrence BIGGS, C539. Phone 402-5684; Fax 474-1412
